HSP90AA1 (HSP90 Alpha Family Class A Member 1)

A molecular chaperone essential for protein folding, stability, and cellular stress response, implicated in cancer and neurodegenerative disorders.

Gene Information Card

Symbol HSP90AA1
Full Name Heat shock protein 90 alpha family class A member 1
Gene Type protein-coding
Chromosomal Location 14q32.31
NCBI Gene ID 3320 ncbi.nlm.nih.gov/gene/3320
Ensembl ID ENSG00000080824
UniProt ID P07900
OMIM ID 140571
HGNC ID 5253
Aliases HSP90A, HSPC1, HSPCA, HSPCAL1, HSP90N, EL52, HEL-S-65p

Description

HSP90AA1 encodes a member of the heat shock protein 90 family, a highly conserved molecular chaperone that facilitates proper folding, stabilization, and function of numerous client proteins involved in cell cycle control, signal transduction, and stress response. It is constitutively expressed and induced by environmental stress. HSP90AA1 plays a critical role in maintaining cellular homeostasis and is implicated in cancer progression and neurodegeneration.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cancer (multiple types) HSP90AA1 overexpression stabilizes oncogenic client proteins (e.g., HER2, EGFR, BCR-ABL), promoting tumor cell survival and proliferation. COSMIC; multiple studies
Neurodegenerative disorders (e.g., Alzheimer's, Parkinson's) HSP90AA1 modulates the aggregation and clearance of misfolded proteins (e.g., tau, alpha-synuclein), influencing disease progression. UniProt; literature
Infectious diseases (e.g., viral infections) HSP90AA1 is hijacked by viruses for replication and assembly; inhibition can reduce viral load. UniProt; literature

Expression Profile

Tissue Expression
Tissue nTPM level
Brain High High expression in cerebral cortex and cerebellum
Heart Moderate Moderate expression in cardiac muscle
Liver High High expression in hepatocytes
Kidney Moderate Moderate expression in renal tubules
Testis High High expression in spermatocytes
Cell Line Expression
Cell Line nTPM Notes
HeLa High Cervical cancer cell line; high HSP90AA1 expression
MCF7 High Breast cancer cell line; high expression
A549 Moderate Lung cancer cell line; moderate expression
HEK293 High Embryonic kidney cells; high expression
K562 Moderate Chronic myeloid leukemia; moderate expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.184G>A (p.Asp62Asn) Missense Rare May affect ATPase activity; clinical significance uncertain
c.719A>G (p.Asn240Ser) Missense Rare Potential impact on chaperone function; not well characterized
c.1102C>T (p.Arg368Cys) Missense Rare Reported in cancer; functional impact unknown
c.1505A>G (p.Glu502Gly) Missense Rare Observed in population databases; no disease association confirmed
Mutation functional classification

Loss of Function (LOF)

Complete loss-of-function mutations are rare and likely lethal due to essential chaperone activity; partial loss may impair protein folding and stress response.

Gain of Function (GOF)

Gain-of-function mutations are not well documented; overexpression is more common in cancer rather than activating mutations.

Dominant Negative (DN)

Dominant-negative mutations have been suggested in some studies, potentially interfering with dimerization and chaperone function, but evidence is limited.

Gene Ontology (GO)

• ATP binding • ATP hydrolysis activity
• chaperone binding • protein folding
• response to heat • cellular response to unfolded protein
• signal transduction • regulation of cell cycle

Pathways

PI3K-Akt signaling pathway
MAPK signaling pathway
Estrogen signaling pathway
Proteasome-mediated ubiquitin-dependent protein catabolic process
Chaperone-mediated autophagy
HSP90 chaperone cycle for steroid hormone receptors (e.g.
glucocorticoid receptor)

Protein Summary

The HSP90AA1 protein is a homodimeric molecular chaperone with ATPase activity. It associates with co-chaperones (e.g., HOP, p23, CDC37) to facilitate client protein maturation. It is essential for the stability and function of many kinases, transcription factors, and steroid hormone receptors. Post-translational modifications include phosphorylation and acetylation, which regulate its activity. HSP90AA1 is a target for cancer therapy; inhibitors like geldanamycin and 17-AAG are under investigation.

Related Products

Product name Cat.No. Species Gene ID
HSP90AA1 Knockout HEK293 Cell Line EDJ-KQ200 Human 3320 Details Get a Quote
HSP90AA1 Knockout A-549 Cell Line EDJ-KQ19537 Human 3320 Details Get a Quote
HSP90AA1 Knockout HCT 116 Cell Line EDJ-KQ19538 Human 3320 Details Get a Quote
HSP90AA1 Knockout HeLa Cell Line EDJ-KQ19539 Human 3320 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: